Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.12-18 01:08

Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592948892?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2025-12-18 01:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592948892","market":"hk","top_or_hot":-1,"title":"Exploring Three High Growth Tech Stocks In The US Market","media":"Simply Wall St.","content":"<div>\n<p>Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/exploring-three-high-growth-tech-stocks-in-the-us-market-9\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exploring Three High Growth Tech Stocks In The US Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExploring Three High Growth Tech Stocks In The US Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-18 01:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/exploring-three-high-growth-tech-stocks-in-the-us-market-9><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/exploring-three-high-growth-tech-stocks-in-the-us-market-9\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4170","symbol_name":"电脑硬件、储存设备及电脑周边","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/exploring-three-high-growth-tech-stocks-in-the-us-market-9","article_id":"2592948892","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/exploring-three-high-growth-tech-stocks-in-the-us-market-9","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592948892","pubTimestamp":1765991307,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the tech-heavy Nasdaq has also seen a recent decline. In this environment, identifying high-growth tech stocks requires careful consideration of companies that demonstrate resilience and potential for innovation despite broader market challenges.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4170":"电脑硬件、储存设备及电脑周边","LU2290526834.HKD":"BGF NEXT GENERATION TECHNOLOGY \"A2\" (HKDHDG) ACC","BK4551":"寇图资本持仓","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","BK4539":"次新股","PSTG":"Pure Storage Inc","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","BK4023":"应用软件","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK4543":"AI","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","NBIX":"神经分泌生物科学","BK4585":"ETF&股票定投概念","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4139":"生物科技","LU0823421333.USD":"BNP PARIBAS DISRUPTIVE TECHNOLOGY \"C\" (USD) ACC","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU0154245756.USD":"BNP PARIBAS US MID CAP \"C\" (USD) ACC","LU0823421416.USD":"BNP PARIBAS DISRUPTIVE TECHNOLOGY \"C\" (USD) INC","BK4587":"ChatGPT概念","BK4528":"SaaS概念","LU0154245673.USD":"BNP PARIBAS US MID CAP \"C\" (USD) INC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","IVVD":"Invivyd, Inc.","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4588":"碎股","AI":"C3.ai, Inc.","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC"},"translate_title":"探索美国市场三只高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBIX":1,"IVVD":1,"PSTG":1,"AI":0.85},"content_text":"Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the tech-heavy Nasdaq has also seen a recent decline. In this environment, identifying high-growth tech stocks requires careful consideration of companies that demonstrate resilience and potential for innovation despite broader market challenges.Top 10 High Growth Tech Companies In The United StatesNameRevenue GrowthEarnings GrowthGrowth RatingADMA Biologics20.12%23.48%★★★★★☆Marker Therapeutics75.24%59.07%★★★★★★Palantir Technologies28.00%32.57%★★★★★★Workday11.15%32.18%★★★★★☆Circle Internet Group23.14%84.30%★★★★★☆RenovoRx71.45%71.45%★★★★★☆Viridian Therapeutics56.24%54.30%★★★★★☆Zscaler15.85%45.93%★★★★★☆Duos Technologies Group53.36%152.11%★★★★★☆Procore Technologies11.76%116.48%★★★★★☆Click here to see the full list of 76 stocks from our US High Growth Tech and AI Stocks screener.Here we highlight a subset of our preferred stocks from the screener.Invivyd (IVVD)Simply Wall St Growth Rating: ★★★★★☆Overview: Invivyd, Inc. is a biopharmaceutical company specializing in antibody-based solutions for infectious diseases in the United States, with a market cap of $517.53 million.Operations: The company's primary revenue stream comes from its focus on the discovery, development, and commercialization of antibody-based solutions for infectious diseases, generating $50.04 million.Invivyd, Inc. has demonstrated a robust commitment to innovation in the biotech sector, particularly with its recent nomination of VBY329 for preclinical development aimed at combating Respiratory Syncytial Virus (RSV). This initiative is part of a broader strategy to explore monoclonal antibodies for various infectious diseases, signaling potential growth in a market projected to reach $3-$4 billion by 2030. Despite facing substantial shareholder dilution this past year and reporting a net loss reduction from $60.74 million to $10.47 million in Q3 2025, Invivyd's aggressive R&D efforts underscore its pursuit of groundbreaking treatments that could revolutionize patient care for vulnerable populations.Delve into the full analysis health report here for a deeper understanding of Invivyd.Gain insights into Invivyd's historical performance by reviewing our past performance report.IVVD Earnings and Revenue Growth as at Dec 2025Neurocrine Biosciences (NBIX)Simply Wall St Growth Rating: ★★★★☆☆Overview: Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally with a market cap of approximately $15.36 billion.Operations: Neurocrine Biosciences focuses on the research, development, and commercialization of pharmaceuticals for neurological and related disorders, generating approximately $2.68 billion in revenue from these activities.Neurocrine Biosciences has been actively enhancing its portfolio with significant R&D investments, as evidenced by their recent strategic alliance to develop NLRP3 inhibitors, potentially worth up to $881.5 million. This move, coupled with a robust pipeline of mid-to-late phase clinical developments across various therapeutic areas, underscores their commitment to addressing complex neurological and neuropsychiatric disorders. Moreover, the company's revenue surged to $2.06 billion over nine months in 2025, marking an impressive growth from the previous year’s $1.73 billion, while net income also rose from $238.2 million to $324.9 million in the same period. These financial achievements reflect Neurocrine's strong operational execution and innovative edge in high-growth tech within biopharmaceuticals.Take a closer look at Neurocrine Biosciences' potential here in our health report.Assess Neurocrine Biosciences' past performance with our detailed historical performance reports.NBIX Earnings and Revenue Growth as at Dec 2025Pure Storage (PSTG)Simply Wall St Growth Rating: ★★★★★☆Overview: Pure Storage, Inc. offers data storage and management solutions globally, with a market cap of $22.97 billion.Operations: Pure Storage generates revenue primarily from its computer storage devices, amounting to $3.48 billion. The company's offerings focus on data storage and management technologies across the U.S. and international markets.Amidst a dynamic tech landscape, Pure Storage stands out with its strategic focus on enhancing AI capabilities and cloud integration. The company's recent earnings reveal a robust upward trajectory in revenue, reaching $2.6 billion over nine months—an increase from the previous year's $2.29 billion. This growth is complemented by an ambitious R&D framework that not only fuels innovation but also aligns with evolving market demands for comprehensive data solutions and cyber resilience. Significant too is Pure Storage's proactive capital management; the firm has repurchased shares worth $480 million since last year, underscoring confidence in its financial health and future prospects. With new leadership aiming to expand global sales and innovative offerings like the AI-powered Pure1 AI Copilot, Pure Storage is adeptly positioned to navigate the complexities of next-gen tech environments.Unlock comprehensive insights into our analysis of Pure Storage stock in this health report.Explore historical data to track Pure Storage's performance over time in our Past section.PSTG Revenue and Expenses Breakdown as at Dec 2025Where To Now?Gain an insight into the universe of 76 US High Growth Tech and AI Stocks by clicking here.Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.Looking For Alternative Opportunities?Explore high-performing small cap companies that haven't yet garnered significant analyst attention.Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.Find companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.The New Payments ETF Is Live on NASDAQ:Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.Explore how this launch could reshape portfoliosSponsored ContentNew: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592948892","isCrawlerRequest":true}